architectures. We apply PLASMA to RNA-Seq data from 524 kidney tumor samples and show 13 that over 17 percent of loci can be fine-mapped to within 5 causal variants, compared less than 2 14 percent of loci using existing QTL-based fine-mapping. PLASMA furthermore achieves a greater 15 power at 50 samples than conventional QTL fine-mapping does at over 500 samples. Overall,
The empirical value of β i is determined with the maximum likelihood estimator, equivalent to the 134 ordinary-least-squares linear regression estimator:
The QTL summary statistic (Wald statistic) for marker i is defined as:
whereσ 2 y,i is calculated from the residuals. i on allele-specific expression is as follows:
Experimentally-derived AS data, such as RNA-Seq data, yield reads that are mapped to a 148 particular haplotype. For a given individual j, let c A,j be the allele-specific read count from
149
Figure 1: Overview of the PLASMA method. (a) Pre-processing of sequence-based data. First, reads are mapped to the sample's genotype. Reads intersecting markers are colored. Then, the sample's genotype is phased. Reads intersecting heterozygous markers can then be mapped to a particular haplotype. Lastly, reads across the locus are aggregated in an allele-specific manner. To visualize this data, the expression is represented by a ring chart, and the genotypes by pedigree symbols. In the ring chart, the diameter signifies the total read count, and the colors signify the proportion of reads coming from each haplotype. For the pedigree symbols, a white circle signifies a wild-type homozygote, a shaded circle signifies a alternative homozygote, and a half-shaded circle signifies a heterozygote. In heterozygotes, the direction of shading corresponds to the direction of heterozygosity (phasing). (b) Visual representation of QTL and AS statistics under a single causal variant,where the alternative allele increases expression. The total expression (y) is determined by the allelic dosage (x), whereas the allelic imbalance (w) is determined by the phasing (v). These two sets of data are used to calculate QTL and AS association statistics (z β and z φ ). (c) Diagram of PLASMA's fine-mapping process. First, QTL and AS statistics are calculated from read data. Then, these statistics, along with an LD matrix, are used to generate probabilities for causal configurations. By searching through the space of these causal configurations, the model produces credible sets and posterior probabilities for each marker.
haplotype A. The allele-specific read count is modeled as drawn a beta-binomial distribution,
given the total mapped read count c j :
151 c A,j ∼ BB(α j , β j , c j )
This beta binomial model is used to estimate the variance of the sampling error τ j : 
where ρ e,j is the overdispersion and w * j is an adjusted estimator of w j to reduce the bias ofσ 2 c,j .
153
(Full derivation in Supplementary Methods).
154
Due to heteroscedasticity among individuals, the AS effect size φ i is estimated in a weighted 155 manner, giving larger weights to individuals with lower estimated sampling error. Given individual 156 j, the weight for j is set as the inverse of the estimated sampling error variance:
Let weight matrix Ω be a diagonal matrix with Ω j,j = ω j . We use the weighted-least-squares 158 estimator for φ i :
With this estimator, the AS association statistic for marker i is calculated as the AS effect size PLASMA defines a joint generative model for total (QTL) and haplotype-specific (AS) effects on 169 expression. Letẑ be the combined vector of AS association statistics and QTL association statistics:
6 Let R z be the genotype LD matrix, and r βφ be a hyperparameter describing the overall correlation 171 between the QTL and AS summary statistics calculated across all loci. Let the combined correlation 172 matrix R as:
The joint z-scores are modeled under a multivariate normal distribution, with covariance R:
PLASMA utilizes a likelihood function that gives the probability of statisticsẑ, given a causal 
Let γ be the prior probability that a single variant is causal and 1 − γ as the probability that a 187 variant is not causal. The prior probability of a configuration consisting of m variants is defined 188 as:
With the prior and likelihood, the posterior probability of a causal configuration, normalized across 190 the set of all possible configurations C is calculated as:
191 P (c|ẑ) = P (ẑ|c)P (c)
PLASMA defines the ρ-level credible set K as the smallest set of markers with a ρ c probability
192
of including all causal markers. Let C K be the set of all causal configurations whose causal markers 193 is a subset of K, excluding the null set. The credible set confidence level ρ c is calculated as the sum
194
of the probabilities of the configurations in C K :
Additionally, PLASMA defines a marker's posterior inclusion probability (PIP) as the probability making no assumption on the relationship between QTL and AS effect sizes.
223
To empirically evaluate the effect of the jointness parameter on fine-mapping performance, 
Generation of simulated loci

229
Genotype data was sampled from phased SNP data using the CEU population in the 1000 Genomes Table S1 .
341
As the performance of standard QTL association models is well established, we first focused on 342 performance of our proposed AS statistic. Figure S3a shows how the mean z φ varies as a function of 343 standard allelic deviation and mean read coverage at a fixed AS heritability of 0.5. Second, Figure   344 S3b shows how the mean z φ varies as a function of standard allelic deviation and heritability with 345 mean coverage fixed at 100. The statistic is the greatest at high read coverage and high heritability, the normal data is shown in Figure S7 . There, PLASMA has higher power for normal samples than
478
for tumor samples, which may be due to the lower variance in the normal data. ChIP fine-mapping results are roughly in line with those from RNA-Seq fine-mapping. across models as a function of posterior probability threshold (computed by Fisher's exact test). gene expression. Let us consider a QTL study of a given locus with n individuals and m markers.
729
Let y be an (n × 1) vector of total expression across the individuals, recentered at zero. Given a 730 marker i, let x i be an (n × 1) zero-recentered vector of genotypes. We define β i , the genetic effect 731 of marker i on total gene expression as follows:
We model the residuals i as normally distributed with variance σ 2 y,i . 
Calculation of QTL summary statistics
734
We use the maximum likelihood estimator of β i , equivalent to the ordinary-least-squares linear 735 regression estimator:
Under the null model where i is not causal, i does not explain any amount of variation of the 737 phenotype, and the variance of y is simply σ 2 y,i . Thus, under the null:
Var (y)
We estimate σ 2 β,i from the residuals:
We thus define our QTL summary statistic (Wald statistic) for marker i as:
We assume that the number of individuals is enough such that the observed statistic is normally 741 distributed with unit variance:
In the case where x i is of unit variance, the statistic simplifies to: contains the alternative marker allele, and 0 if the individual is homozygous for the marker.
759
We now re-write Equation 29 as a linear model. Let w be the log expression ratio between 760 haplotypes A and B:
Let φ i be the log allelic fold change (logAFC) caused by variant i:
Let ζ i be the log baseline expression ratio between haplotypes A and B:
With these parameters we rewrite Equation 29 as:
Given n individuals, this expression becomes:
We assume that ζ i is drawn from a normal distribution with variance σ 2 w,i . Note that under Experimentally-derived AS data, such as RNA-Seq data, yield reads that are mapped to a 770 particular haplotype. Given c A and c B , the read counts mapped to haplotypes A and B respectively,
771
we define our estimator of w as:
For a given individual j, we define c A,j as the allele-specific read count from haplotype A. We 773 model the allele-specific read count as drawn a beta-binomial distribution, given the total mapped 774 read count c j :
We define π j as the expected proportion of read counts (allelic fraction) from haplotype A:
α j and β j can be re-parameterized in terms of π j and the sampling overdispersion ρ e .
With this re-paramaterization, the mean and variance of c A,i is given as follow:
We use this beta binomial model to estimate the variance ofŵ i . We scale the distribution by to get the mean and variance for the read count proportion:
We define w * as the logit-transformed allelic fraction:
We can thus find the approximate mean and variance ofŵ j given w * j using Taylor expansions:
Note that w and w * are not equivalent because
]). Equation 46
788 implies thatŵ is a biased estimator of w * , especially at low read counts and/or high overdispersion.
789
To get an estimator of w * with reduced bias, we take the approximation that sinh(w * ) ≈ w * around 790 zero:
We useŵ * to find an estimator of σ 2 c,j , the variance ofŵ:
Given our estimatorŵ j , we quantify the sampling error τ j =ŵ j − w j , with E [τ j ] = 0 and 793 Var (τ j ) = σ 2 c,j . Thus, across individuals:
Calculation of AS summary statistics
795
Due to heteroscedasticity among individuals, we estimate the AS effect size φ i in a weighted manner,
796
giving larger weights to individuals with lower expected sampling error. Given individual j, we 797 define the weight for j as the inverse of the estimated read count variance:
We define our weight matrix Ω as a diagonal matrix with Ω j,j = ω j .
799
We use the weighted-least-squares estimator for φ i :
Under the null model where i is not causal, the variance of w j is σ 2 w,i , and the variance ofŵ j is 801 σ 2 w,i + σ 2 c,j . We assume that the experimental errors τ and biological residuals ζ i are uncorrelated.
802
Thus, under the null:
We now estimate σ 2 w,i from the residuals. Note that we are estimating the variance of the biological 804 residuals Var (ζ i ), which is distinct from the total residuals are ζ i + τ, so we cannot directly use 805 the variance of the total residuals. We instead use the following estimator for σ 2 w,i :
We show that this estimator is equal to σ 2 φ,i in expectation:
With this estimator, we define the AS association statistic for marker i as follows:
We assume that the observed statistic is normally distributed with unit variance:
To gain an intuitive understanding of the association statistic, let us examine it under simplifying 810 conditions. We assume that v i is of unit variance, that read count overdispersion is negligible, and 
We can see that under high experimental noise (k/c), the denominator is dominated by the quality 814 of data (read coverage). In contrast, when experimental noise is low, the denominator is dominated 815 byσ 2 w,i , determined by the inherent heritability of the locus's AS phenotype.
816
In the case where phasing error is significant, we would expect the estimated AS effects (φ)
817
to have more deviation from the true effects. We derive a correction for the AS z-score, given 818 a per-marker probability of mis-phasing ψ i . We definev i as the imperfect observed phasing for 819 marker i, and we define the phasing error vector δ i such that
ternary -2/0/2 indicator, with each δ 2 being a binary 0/4 indicator of a phasing error. We assume 821 that the occurence of a phasing error is independent of which haplotype the alternative allele is 822 one, so that E [δ i ] = 0. We now derive the variance ofφ i under imperfect phasing:
824
When calculating Var φ i , we approximate the φ 2 i term with the observed φ 2 i . We thus define 825 the corrected z-score: error is the probability that a given marker is misphased, with downstream markers unaffected,
Emprical Analysis of Imperfect Phasing
833
and was set to 0.165%.
834
Results for these imperfectly-phased loci are shown in Figure S5 , genotype data at sample sizes ranging from 50 to 1000. We then calculate LD matrices using each 851 estimator and compare the estimated correlations for each pair of markers. In Figure S1 , we see 852 that correlation among the estimators increases as a function of sample size, and also that a sam-
853
ple size of 50 is more than sufficient for high concordance among the three estimators. Since the 854 haplotype-specific estimator appears to be more correlated to both the dosage estimator and the 855 phasing estimator than the latter two are to each other, we use the haplotype-specific estimator in 856 our analyses. We believe that the haplotype-specific estimator is the most accurate of the three 857 since it as effectively double the sample size as the dosage and phasing estimators. 
864
Let a be a binary genetic marker, and let p a be a random variable for the (0/1) genotype of a 865 on haplotype I (arbitrarily chosen), and let q a be a random variable for the (0/1) genotype of a on 866 haplotype II.
867
We define the dosage genotype of marker a as the sum of the centered haplotypes:
Likewise, we define the phasing genotype of marker a as the difference of the centered haplotypes: 
We make the assumption that the two alleles in an individual are independent, so that the covariance 874 of any p and q is zero. The covariance simplifies to:
We calculate the correlation of x a and x b from this correlation, and we see that it is equivalent to 876 the correlation of p a and p b :
Under the same assumptions, we calculate the covariance of v a and v b .
We see that the covariance of v a and v b is equal to the covariance of x a and x b , implying that the selection, but we assume that selection is insignificant due to the weak effects of common markers.) We defineẑ as the combined vector of AS association statistics and QTL association statistics:
Let r βφ be the overall correlation between the QTL and AS summary statistics calculated across 887 all loci. We define the combined correlation matrix R as:
We model the joint distribution as multivariate normal, with covariance R:
Modeling summary statistics given a causal configuration
The goal of this method is to infer the causal markers, given QTL and AS association statistics. To 891 this end, we introduce a likelihood function that gives the probability of statisticsẑ, given a causal 892 configuration. We define a causal configuration c as a vector of causal statuses corresponding to 893 each marker, with 1 being causal and 0 being non-causal.
894
Let z c,φ and z c,β be the underlying causal AS and QTL effects, respectively, across markers 895 such that:
We define hyperparameters σ 2 c,φ and σ 2 c,β as the variance of AS and QTL causal effect sizes, respec-897 tively r c,βφ as the underlying correlation of the causal QTL and AS effect sizes. (This is not to be 898 confused with r βφ , which concerns the correlation between the association statistics.) We define 899 Σ c , the covariance matrix of causal effect sizes, given a causal configuration:
We model the causal effect sizes, given a causal configuration, as drawn from a multivariate normal
Furthermore, we model the expected association statistic for a given marker as a linear combination 903 of all effects correlated to the marker.
Combining Equations 70 and 75, we get a probability distribution for the observed association 906 statistics given a causal configuration. This is our likelihood for a causal configuration. |c ∼ N 2m (0, R + RΣ c R)
To get a prior distribution for the causal configuration c, we define the hyperparameter γ as 908 the prior probability that a single variant is causal and 1 − γ as the probability that a variant is 909 not causal. The probability of a configuration consisting of m variants thus becomes:
We can view the prior as a regularization term by taking the negative log:
Since c is a binary vector, c k is the same for all positive k. Thus, the prior imposes L k regular- 
36
With the prior and likelihood, we define the posterior probability of a causal configuration,
915
normalized across the set of all possible configurations C:
This posterior probability can be alternatively expressed with Bayes Factors. We define the 917 null model as the scenario where all markers are non-causal, so that c = 0. The Bayes Factor for 918 a particular c would thus be:
We rewrite Equation 79 with Bayes Factors:
5.3.5 The ρ-level credible set
921
In practice, due to the large number of possible configurations, the probability of any given config-922 uration will likely be small. For more meaningful probabilities, we calculate the total probability 923 of the possible non-null configurations from a set of markers.
924
We define K as a set of markers that putatively includes all causal markers. We define C K
925
as the set of all causal configurations whose causal markers is a subset of K, excluding the null 926 set. Thus, the probability that K includes all causal markers is the sum of the probabilities of the
We set this probability as ρ c , the confidence level of K. Given a value for ρ c , commonly 0.95, we 929 seek to find K that minimizes the number of causal variants. An alternative way of summarizing the configurations is to calculate a marker's posterior inclusion 932 probability (PIP), also known as the posterior probability of association. We define the PIP as the 933 probability that a single given marker is causal, marginalized over all other markers. We calculate 934 this probability by summing over all configurations containing the marker. configurations with significant probabilities tend to be similar to each other.
941
We use a shotgun stochastic search procedure based on that of FINEMAP to find all config-
942
urations with a signifcant probability [15] . Given a selected configuration c, we define G c , the 
We permute s to separate causal and non-causal SNPs:
We likewise permute the rows and columns of R and Σ c such that:
Note that Σ c can be nonzero only among causal markers since c is 0 for non-causal markers.
967
Furthermore:
Blockwise inversion yields: 
